Delirium drug may not benefit critically ill patients, study finds

08/20/2013 | HealthDay News

The antipsychotic drug haloperidol was no more effective than placebo in treating delirium in critically ill patients, according to a study in The Lancet Respiratory Medicine. Researchers tracked 141 seriously ill patients and found that the drug had no effect on length of delirium. Haloperidol also failed to cut death rates, time on ventilators or duration of hospitalization.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC